via AI.Nony.Mous
Finding could revolutionise how all vaccines could be made to be longer lasting
The SARS-Cov-2 pandemic illustrates how variable vaccines can be in their length of efficacy, with regular boosters needed to keep people protected. In comparison, the immunity generated by a single vaccination against the measles virus can last decades.
It has always remained a scientific mystery as to why only some vaccines lead to life-long protection. Now a paper published in the journal, Immunity, led by Prof. David Tarlinton and Dr Marcus Robinson, both from Monash University’s Central Clinical School in Melbourne, Australia, has found that the clue likely lies in the body producing a unique subtype of an immune cell in response to some but not other vaccinations. The finding could revolutionise how all vaccines could be made to be longer lasting.
Vaccines trick our immune cells into thinking the body has been infected. In response, we produce antibodies to fight off what is perceived as an infection. According to Dr Robinson, “most vaccines work by generating high levels of antibodies against these invaders, but how long these antibodies persist in the body is highly variable by vaccine,” he said. “Now we know that the clue is in whether vaccines generate a special subtype of immune cell that produces antibody for long times to fight off infection indefinitely.”
Using an animal model, the researchers studied the lifespan of antibody-secreting cells, identifying surface markers on these cells that indicated longevity. The scientists used a method called ‘timestamping’, which effectively tracks individual antibody-secreting cells across their entire lifespan. “We found those cells with particular markers on them were more likely to be long lasting. They also expressed really distinct patterns of genes, so we think longevity is programmed into the cell.” Dr Robinson said.
“It is these cells we need to target when developing vaccines we want to provide long-lasting protection.”
Importantly the researchers also found that there is a maximum number of these long-lasting antibody-secreting cells the body can hold at any one time, and they generally reside in special sites in tissues like the bone marrow – so improved vaccines will need to focus on maintaining these reservoirs of long acting cells, according to Dr Robinson.
Original Article: Making vaccines longer lasting
More from: Monash University
The Latest Updates from Bing News
Go deeper with Bing News on:
Long lasting vaccines
- Long flu season winds down in US
The U.S. flu season appears to be over. It was long, but federal health officials and doctors say it was a moderate one.
- U.K. Tests World-First Personalized Skin Cancer Vaccine
Customized with genetic information from a patient’s own tumor, vaccines like this could one day be used against lung, kidney, bladder and colon cancer.
- First mRNA skin-cancer vaccine starts UK trial
A n important trial of the world's first "personalised" mRNA vaccine against the deadliest form of skin cancer - melanoma - is now under way in the UK. Steve Young, 52, from Stevenage, Herts, who had ...
- Cancer breakthrough as scientists develop super vaccine that could provide miracle cure
Harnessing the same technology used to defeat the Covid pandemic, the mRNA jab is custom-built in a matter of weeks and given after surgery to stop the disease returning. Experts hailed it as the ...
- Demand for the cholera vaccine is soaring – this company might have a solution
In the global race to provide enough vaccines to tackle the ever-growing threat posed by cholera, one company is leading the field.
Go deeper with Bing News on:
Life-long protection vaccines
- World Immunisation Week 2024: 5 most important vaccines for infants and children
Know which vital vaccines safeguard our youngest ones during World Immunisation Week 2024. Uncover the top five crucial vaccines for infants and children, ensuring their health and well-being.
- A Universal Vaccine Against Any Viral Variant? A New Study Suggests It’s Possible
A universal vaccine would train the body to recognize and eradicate new viral strains, even if they've mutated into nearly unrecognizable forms.
- Less than half of nursing home residents are up to date with their COVID-19 vaccines, study finds: Your guide to the latest virus news
Here’s your go-to guide with everything you need to know about COVID-19, including testing expanding to more airports, updated isolation guidelines and plans for a fall vaccine.
- Dengue Vaccine Development: Challenges and Emerging Opportunities
the vaccine should provide life-long protection to all four serotype of dengue virus, thus a potential vaccine must be tetravalent; second, the cost of vaccine should be lower and affordable for ...
- New vaccine strategy offers lifelong protection for infants: study
NEW YORK, April 16: A groundbreaking study proposes a novel vaccine approach for infants that could provide lasting protection against a range of diseases with just one dose, even amidst virus ...